Kurome Therapeutics
PrivateLast Round
Series A
Jun 10, 2021
Total Funding Raised
$19M
Company Overview
Kurome Therapeutics operates in Healthcare & Life Sciences and is based in Cincinnati, Ohio. Its latest recorded funding round was a Series A round in June 2021.
Kurome Therapeutics is a biotechnology company that develops small-molecule therapies targeting dysregulated immune signaling pathways in hematological cancers such as acute myeloid leukemia and myelodysplastic syndromes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kurome Therapeutics Comparables
Compare Kurome Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eilean Therapeutics | 93% | |
| Arog Pharmaceuticals | 86% | |
| Hangzhou Polymed Biopharmaceuticals | 83% |
For institutional investors. Book with your work email.
Kurome Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 10, 2021 | ||||
| Seed | Apr 29, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kurome Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QCA Ventures | Seed, Series A |
| CincyTech | Series A, Seed |
| Angel Physicians Fund | Seed |
| Medicxi | Series A |
| Affinity Asset Advisors | Series A |
Kurome Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kurome Therapeutics's valuation, stock price, and market status.
Is Kurome Therapeutics a public or private company?
Kurome Therapeutics is a private company.
What is the current stock price of Kurome Therapeutics?
Kurome Therapeutics is a private company, so its shares have no public market price. Caplight tracks Kurome Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kurome Therapeutics worth (valuation)?
Valuation information for Kurome Therapeutics is not publicly available.
Can I buy Kurome Therapeutics stock?
Kurome Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kurome Therapeutics's last funding round?
Kurome Therapeutics's most recent funding round was Series A on June 10, 2021.
Who are the main investors in Kurome Therapeutics?
Key investors in Kurome Therapeutics include CincyTech, Medicxi, Affinity Asset Advisors.
Will Kurome Therapeutics IPO soon?
No public IPO plans have been announced for Kurome Therapeutics.
How can I track Kurome Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Kurome Therapeutics's shares on secondary markets.